我国药品短缺原因分析及供应保障对策
|
摘要
目的:分析我国出现药品短缺的原因,为完善我国药品短缺供应保障体系提出建议。方法:采用文献研究法,探讨我国药品短缺的原因,提出短缺药品的供应保障措施。结果:药品供应链(研发、生产、流通、采购、使用的各个环节)、药物相关政策、突发事件等因素是目前导致我国出现药品短缺的主要原因。结论:建立以应急措施和长效保障措施相结合的短缺药品供应保障机制,多措并举,动态调整短缺药品清单和短缺药品价格、落实低价药品供应保障政策、加强医药卫生体制改革联动、建立相关奖惩制度,最大程度地减少药品短缺事件的发生,降低发生药品短缺带来的危害。
Objective To analyze the causes of medicine shortage in China,and put forward suggestions for improving the supply guarantee. Methods The causes of medicine shortage in China was studied with literature research method. Results The main causes of medicine shortage in China were medicine supply chain( including research and development,production,circulation,procurement and use),medicine-related policies and emergencies. Conclusion It is suggested to establish a supply guarantee mechanism combining emergency measures with long-term safeguard measures,dynamically adjust the list and prices of shortage medicines,ensure the supply of low-priced medicines,strengthen the linkage of the reform on medical and health system,and establish related incentives and penalties.
Objective To analyze the causes of medicine shortage in China,and put forward suggestions for improving the supply guarantee. Methods The causes of medicine shortage in China was studied with literature research method. Results The main causes of medicine shortage in China were medicine supply chain( including research and development,production,circulation,procurement and use),medicine-related policies and emergencies. Conclusion It is suggested to establish a supply guarantee mechanism combining emergency measures with long-term safeguard measures,dynamically adjust the list and prices of shortage medicines,ensure the supply of low-priced medicines,strengthen the linkage of the reform on medical and health system,and establish related incentives and penalties.
引文
[1]陶立波.发达国家应对药品短缺问题的经验及启示[J].中国卫生政策研究,2008,1(3):38-42.
[2]蔡文芳,杨才君,沈倩,等.国内外药品短缺问题研究进展[J].中国药事,2016,30(12):1190-1199.
[3]袁雪丹,傅鸿鹏.全球药品短缺管理及其对我国的启示[J].中国卫生经济,2016,35(11):60-63.
[4] WEERDT E,SIMOENS S,CASTEELS M,et al. Toward a Europeandefinition for a drug shortage:a qualitative study[J]. Frontiers inpharmacology,2015(6):253.
[5]李勇,盛亚楠,赵梦蕊,等.供应链视角下我国药品短缺原因及供应保障研究[J].卫生经济研究,2017(6):55-59.
[6]刘玉丹,冯国忠.我国部分临床短缺药品供应保障措施探讨[J].中国药事,2017(7):711-715.
[7]李勇,赵梦蕊,马爱霞,等.我国仿制药一致性评价对药品短缺的影响分析[J].卫生经济研究,2017(05):47-50.
[8]徐伟伟,蒋峰.临床部分药品短缺成因探讨[J].中国药房,2008(7):493-496.
[9]盛亚楠,李勇,马爱霞,等.我国短缺药品供应保障政策研究[J].卫生经济研究,2017(8):57-60.
[10]何梦婷,冯国忠,周振,等.国外药品短缺处理机制的比较及对我国的启示[J].中国药事,2017(9):980-983.
[11]吕佳,罗震旻,陈吉生.基于数据库模型的短缺基本药物保障措施研究[J].中国卫生经济,2013(9):25-29.
[12]谭思然,蒲川.实现医保对医疗行为监管模式转变的路径思考[J].中国卫生事业管理,2018,35(07):507-508+524.
[13]伍红艳,徐扬,冉雪蓉,等.影响医务人员主动上报医疗不良事件因素的因子分析[J].中国卫生事业管理,2018,35(07):496-498+520.
[14]刘倩楠,孙静,刘远立.应对药品短缺保障供应的国际实践及对我国的启示[J].中国药房,2017,28(18):2452-2455.
[2]蔡文芳,杨才君,沈倩,等.国内外药品短缺问题研究进展[J].中国药事,2016,30(12):1190-1199.
[3]袁雪丹,傅鸿鹏.全球药品短缺管理及其对我国的启示[J].中国卫生经济,2016,35(11):60-63.
[4] WEERDT E,SIMOENS S,CASTEELS M,et al. Toward a Europeandefinition for a drug shortage:a qualitative study[J]. Frontiers inpharmacology,2015(6):253.
[5]李勇,盛亚楠,赵梦蕊,等.供应链视角下我国药品短缺原因及供应保障研究[J].卫生经济研究,2017(6):55-59.
[6]刘玉丹,冯国忠.我国部分临床短缺药品供应保障措施探讨[J].中国药事,2017(7):711-715.
[7]李勇,赵梦蕊,马爱霞,等.我国仿制药一致性评价对药品短缺的影响分析[J].卫生经济研究,2017(05):47-50.
[8]徐伟伟,蒋峰.临床部分药品短缺成因探讨[J].中国药房,2008(7):493-496.
[9]盛亚楠,李勇,马爱霞,等.我国短缺药品供应保障政策研究[J].卫生经济研究,2017(8):57-60.
[10]何梦婷,冯国忠,周振,等.国外药品短缺处理机制的比较及对我国的启示[J].中国药事,2017(9):980-983.
[11]吕佳,罗震旻,陈吉生.基于数据库模型的短缺基本药物保障措施研究[J].中国卫生经济,2013(9):25-29.
[12]谭思然,蒲川.实现医保对医疗行为监管模式转变的路径思考[J].中国卫生事业管理,2018,35(07):507-508+524.
[13]伍红艳,徐扬,冉雪蓉,等.影响医务人员主动上报医疗不良事件因素的因子分析[J].中国卫生事业管理,2018,35(07):496-498+520.
[14]刘倩楠,孙静,刘远立.应对药品短缺保障供应的国际实践及对我国的启示[J].中国药房,2017,28(18):2452-2455.